Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus.

Medeiros Sde O, Abreu CM, Delvecchio R, Ribeiro AP, Vasconcelos Z, Brindeiro Rde M, Tanuri A.

J Feline Med Surg. 2016 Apr;18(4):264-72. doi: 10.1177/1098612X15580144. Epub 2015 Apr 8.

PMID:
25855689
2.

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

Arai M, Earl DD, Yamamoto JK.

Vet Immunol Immunopathol. 2002 Mar;85(3-4):189-204.

PMID:
11943320
3.

Combined effect of zidovudine (ZDV), lamivudine (3TC) and abacavir (ABC) antiretroviral therapy in suppressing in vitro FIV replication.

Bisset LR, Lutz H, Böni J, Hofmann-Lehmann R, Lüthy R, Schüpbach J.

Antiviral Res. 2002 Jan;53(1):35-45.

PMID:
11684314
4.
5.
6.

Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection.

Gómez NV, Fontanals A, Castillo V, Gisbert MA, Suraniti A, Mira G, Pisano PB.

Viruses. 2012 Jun;4(6):924-39. doi: 10.3390/v4060924. Epub 2012 May 30.

7.
8.

Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms.

Hartmann K, Donath A, Beer B, Egberink HF, Horzinek MC, Lutz H, Hoffmann-Fezer G, Thum I, Thefeld S.

Vet Immunol Immunopathol. 1992 Dec;35(1-2):167-75.

PMID:
1363008
9.

Effect of 3'azido-2',3'-deoxythymidine (AZT) on experimental feline immunodeficiency virus infection in domestic cats.

Smyth NR, Bennett M, Gaskell RM, McCracken CM, Hart CA, Howe JL.

Res Vet Sci. 1994 Sep;57(2):220-4.

PMID:
7817010
10.

Prophylactic ZDV therapy prevents early viremia and lymphocyte decline but not primary infection in feline immunodeficiency virus-inoculated cats.

Hayes KA, Lafrado LJ, Erickson JG, Marr JM, Mathes LE.

J Acquir Immune Defic Syndr. 1993 Feb;6(2):127-34.

PMID:
8381867
11.

Fozivudine tidoxil as single-agent therapy decreases plasma and cell-associated viremia during acute feline immunodeficiency virus infection.

Fogle JE, Tompkins WA, Campbell B, Sumner D, Tompkins MB.

J Vet Intern Med. 2011 May-Jun;25(3):413-8. doi: 10.1111/j.1939-1676.2011.0699.x. Epub 2011 Apr 1.

12.
14.
15.

Resolution and prevention of feline immunodeficiency virus-induced neurological deficits by treatment with the protease inhibitor TL-3.

Huitron-Resendiz S, De Rozières S, Sanchez-Alavez M, Bühler B, Lin YC, Lerner DL, Henriksen NW, Burudi M, Fox HS, Torbett BE, Henriksen S, Elder JH.

J Virol. 2004 May;78(9):4525-32.

16.

16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.

Pedersen NC, North TW, Rigg R, Reading C, Higgins J, Leutenegger C, Henderson GL.

Vet Immunol Immunopathol. 2003 Aug 15;94(3-4):133-48.

PMID:
12909410
18.

Domestic cats infected with lion or puma lentivirus develop anti-feline immunodeficiency virus immune responses.

VandeWoude S, Hageman CL, Hoover EA.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):20-31.

PMID:
14501789
19.

The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance.

Galilee M, Alian A.

PLoS Pathog. 2018 Jan 24;14(1):e1006849. doi: 10.1371/journal.ppat.1006849. eCollection 2018 Jan.

20.

Efficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novavir trial).

Joly V, Flandre P, Meiffredy V, Brun-Vezinet F, Gastaut JA, Goujard C, Remy G, Descamps D, Ruffault A, Certain A, Aboulker JP, Yeni P; Novavir Study Group.

Antimicrob Agents Chemother. 2002 Jun;46(6):1906-13.

Supplemental Content

Support Center